Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ science, today announced the formal launch of the first drug candidate of NAD Pharmaceuticals Corp., its wholly owned subsidiary ...

Beyond the effects of breathing the deadly dust, the psychological impact is taking an immense physical toll, an SBU study ...

Two new studies found 80-90% improvement in health outcomes and $9,000 per patient savings on average for Health ...

United Therapeutics, a biotechnology company with co-headquarters and manufacturing facilities in Research Triangle Park, has acquired a Boston-area biotech company to boost its efforts in ...

USC researcher Karolina Charaziak, PhD, has been awarded a $3.3 million National Institutes of Health (NIH) Research Project ...